Summary
Hyperinsulinaemia is a reported feature of the inherited multisystem disorder myotonic dystrophy. This phenomenon has been attributed to a compensatory beta cell response to tissue insulin resistance. In this study, circulating concentrations of insulin, proinsulin, and split proinsulin molecules were determined after an overnight fast in ten patients with myotonic dystrophy using two-site monoclonal antibody-based immunoradiometric assays. Results were compared with ten healthy control subjects matched for age, gender, and body mass index. Oral glucose tolerance (75 g), as defined by World Health Organization criteria, was normal in all subjects. Fasting plasma immunoreactive insulin concentration, as determined using a conventional radioimmunoassay, was almost three times higher (p<0.005) in the myotonic dystrophy patients than the healthy control subjects. By contrast, fasting concentrations (mean±SEM) of C-peptide (0.75±0.09 vs 0.52±0.03 nmol/l, p=0.07) and immunoradiometrically-determined insulin (60±12 vs 38±4 pmol/l, p=0.09) were not significantly different between the groups. Fasting concentrations of proinsulin (10.3±2.9 vs 1.6±0.3 pmol/l, p<0.01), and 32–33 split proinsulin (7.8±2.5 vs 2.9±0.4 pmol/l, p<0.05) were significantly elevated in the patients with myotonic dystrophy. Accordingly, the mean fasting proinsulin∶insulin ratio, expressed as a percentage, was significantly increased in the myotonic patients (20±5 vs 4±1%, p<0.01). The overall C-peptide response to the oral glucose challenge was significantly greater in the myotonic patients compared with the healthy control subjects (p<0.001). These results provide corroborative evidence of increased beta-cell secretion in myotonic dystrophy. In addition, myotonic dystrophy is characterised by elevated plasma concentrations of proinsulin-like molecules which may cross-react in insulin radioimmunoassays.
Article PDF
Similar content being viewed by others
References
Krentz AJ, Coles NH, Williams AC, Nattrass M (1990) Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy. Metabolism 39: 938–942
Krentz AJ, Williams AC, Nattrass M (1991) Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy. Metabolism 40: 866–872
Flier JS (1983) Insulin receptors and insulin resistance. Annu Rev Med 34: 145–160
Poffenbarger PL, Pozefsky T, Soeldner JS (1976) The direct relationship of proinsulin-insulin hypersecretion to basal serum levels of cholesterol and triglyceride in myotonic dystrophy. J Lab Clin Med 87: 384–396
Williams DRR, Byrne C, Clark PMS et al. (1991) Raised proinsulin concentration as early indication of B cell dysfunction. Br Med J 303: 95–96
Temple RC, Carrington CA, Luzio SD et al. (1989) Insulin deficiency in non-insulin-dependent diabetes. Lancet I: 293–295
Sobey WJ, Beer SF, Carrington CA et al. (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260: 535–541
Diabetes Mellitus. Report of a WHO Study Group (1985) World Health Organization Technical Report Series no. 727, Geneva
Peavy DF, Brunner MR, Duckworth WC, Hooker CS, Frank BH (1985) Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats. J Biol Chem 260: 13 989–13 994
Unger RH, Grundy S (1985) Hyperglycaemia as an inducer as well as a consequence of impaired islet function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119–121
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krentz, A.J., Clark, P.M., Cox, L. et al. Hyperproinsulinaemia in patients with myotonic dystrophy. Diabetologia 35, 1170–1172 (1992). https://doi.org/10.1007/BF00401372
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401372